$13.88
-0.26-1.84%
At close: -
$13.81
-0.07-0.50%
After Hours: 6:57 PM EDT
Comments
Loading...
Niagen Bioscience (NAGE) Forecast
NewsEarningsNiagen Bioscience (NAGE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Niagen Bioscience Stock Price, Quotes and Forecasts | NASDAQ:NAGE | Benzinga
Explore Niagen Bioscience stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NAGE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Niagen Bioscience (NAGE) stock?
You can purchase shares of Niagen Bioscience (NASDAQ:NAGE) through any online brokerage.
Who are Niagen Bioscience (NAGE) competitors?
Other companies in Niagen Bioscience’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solutions (NASDAQ:BLFS) and Waters (NYSE:WAT).
What is the forecast, or price target, for Niagen Bioscience (NAGE) stock?
Niagen Bioscience has a consensus price target of $16.67.
What is the current price for Niagen Bioscience (NAGE)?
The stock price for Niagen Bioscience (NASDAQ: NAGE) is $13.81 last updated June 17, 2025 at 6:57 PM EDT.
Does Niagen Bioscience (NAGE) pay a dividend?
There are no upcoming dividends for Niagen Bioscience.
When is Niagen Bioscience (NASDAQ:NAGE) reporting earnings?
Niagen Bioscience’s Q2 earnings are confirmed for Wednesday, August 6, 2025.
Is Niagen Bioscience (NAGE) going to split?
There is no upcoming split for Niagen Bioscience.
What sector and industry does Niagen Bioscience (NAGE) operate in?
Niagen Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
